marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
AcelRx Pharmaceuticals Cash Flow 2011-2024 | ACRX
Annual Cash Flow AcelRx Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.5 M | -28.3 M | -30 M | -38.5 M | -51.2 M | -29.1 M | -29.8 M | -29.4 M | -20 M | - | -487 K | -24.6 M | -15.3 M |
Depreciation & Amortization |
311 K | 1.65 M | 1.97 M | 1.85 M | 1.67 M | 575 K | 1.74 M | 2.05 M | 1.98 M | 866 K | 593 K | 605 K | 513 K |
Accounts Payables |
1.34 M | 1.26 M | 2.12 M | 2.74 M | 1.72 M | 2.07 M | 1.42 M | 1.56 M | 1.56 M | 2.43 M | 2.34 M | 2.24 M | 1.53 M |
Accounts Receivables |
- | - | 160 K | 635 K | 432 K | 49 K | 1.53 M | 5.83 M | 3.29 M | - | - | - | - |
Total Inventories |
- | - | 1.11 M | 1.63 M | 3.3 M | 854 K | 956 K | 2.15 M | 466 K | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow AcelRx Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -2.88 M | - | - | - | -5.25 M | - | -22.9 M | -17.7 M | -8.93 M | - | -22 M | -18.1 M | -9.71 M | - | -32.2 M | -24.1 M | -14.4 M | - | -37 M | -25.6 M | -13.2 M | - | -20.1 M | -13.8 M | -7.37 M | - | -23.1 M | -16.3 M | -7.54 M | - | -19.1 M | - | - | - | - | - | - | - | - | - | -10.1 M | - | - | - | -9.67 M | - | -18.8 M | -12.1 M | -7.76 M | - | -9.3 M | -5.03 M | -1.38 M |
Depreciation & Amortization |
- | - | - | - | - | - | 262 K | - | 1.3 M | 881 K | 420 K | - | 1.51 M | 1.03 M | 450 K | - | 1.47 M | 979 K | 487 K | - | 1.15 M | 734 K | 328 K | - | 435 K | 293 K | 149 K | - | 1.39 M | 948 K | 480 K | - | 1.54 M | 1.03 M | 512 K | - | 1.5 M | 997 K | 488 K | - | 469 K | 318 K | 162 K | - | 439 K | 288 K | 141 K | - | 467 K | 336 K | 164 K | - | 348 K | 232 K | 117 K |
Accounts Payables |
396 K | 808 K | 1.27 M | 1.34 M | 1.03 M | 1.21 M | 1.4 M | 1.26 M | 2 M | 2.4 M | 2.72 M | 2.12 M | 2.23 M | 1.94 M | 3.24 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 1.72 M | 1.72 M | 1.72 M | 1.72 M | 2.07 M | 2.07 M | 2.07 M | 2.07 M | 1.42 M | 1.42 M | 1.42 M | 1.42 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 2.43 M | 2.43 M | 2.43 M | 2.43 M | 2.34 M | 2.34 M | 2.34 M | 2.34 M | 2.24 M | 2.24 M | 2.24 M | 2.24 M | 1.53 M | 1.53 M | 1.53 M | 1.53 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | 512 K | 364 K | 184 K | 160 K | 153 K | 104 K | 658 K | 635 K | 635 K | 635 K | 635 K | 432 K | 432 K | 432 K | 432 K | 49 K | 49 K | 49 K | 49 K | 1.53 M | 1.53 M | 1.53 M | 1.53 M | 5.83 M | 5.83 M | 5.83 M | 5.83 M | 3.29 M | 3.29 M | 3.29 M | 3.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | 874 K | 901 K | 1.04 M | 1.11 M | 1.56 M | 1.36 M | 1.42 M | 1.63 M | 1.63 M | 1.63 M | 1.63 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 854 K | 854 K | 854 K | 854 K | 956 K | 956 K | 956 K | 956 K | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 466 K | 466 K | 466 K | 466 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency